Why is it important to receive Inmazeb if I need it?

Inmazeb is used to treat Ebola, which can be a deadly infection if not properly cared for. [Signs and symptoms](https://www.cdc.gov/vhf/ebola/symptoms/index.html) include fever, aches and pains, weakness and fatigue, and stomach problems. Ebola is [spread](https://www.cdc.gov/vhf/ebola/transmission/index.html) through direct contact with an object or bodily fluid contaminated with Ebola virus. If you think you've been exposed to Ebola, seek medical attention right away so you can be tested and treated appropriately.

Is Inmazeb readily available?

If you're located in the U.S., Inmazeb might not be readily available. There are selected healthcare facilities in the U.S. that are called [designated Ebola treatment centers](https://www.cdc.gov/vhf/ebola/healthcare-us/preparing/treatment-centers.html) and might carry this treatment. The manufacturer (Regeneron) is [currently supplying](https://investor.regeneron.com/news-releases/news-release-details/regenerons-antibody-cocktail-regn-eb3-inmazebr-first-fda) the Biomedical Advanced Research and Development Authority (BARDA) with a limited number of Inmazeb until 2026. This is part of the U.S. Department of Health and Human Services' (HHS) goal to be prepared for future public health emergencies. One of Regeneron's other priorities is working to make sure people in low- and middle-income countries where Ebola is more common, like the Democratic Republic of the Congo (DRC), can get this treatment.

Inmazeb

Q: What are common side effects with Inmazeb?

[Common side effects](https://www.inmazeb.com/#aboutSection) that people experienced during and immediately after the infusion include fever, chills, fast heart rate, fast breathing rate, vomiting, low blood pressure, and diarrhea.

atoltivimab / maftivimab / odesivimab

Used for Ebola

Inmazeb is a combination medication containing atoltivimab, maftivimab, and odesivimab (also called odesivimab-ebgn). It's used to treat Ebola, a viral infection that can cause serious complications. This treatment is given as an intravenous (IV) infusion by a healthcare provider.

Reviewed by:

Robert Chad Hakim, PharmD, BCCCP

Kristianne Hannemann, PharmD

Last reviewed on April 5, 2022

What is Inmazeb?

Drug facts

Common Brands	Inmazeb
Drug Class	Monoclonal antibody
Controlled Substance Classification	Not a controlled medication
Generic Status	No lower-cost generic available
Availability	Prescription only

Common Brands

Inmazeb

Drug Class

Monoclonal antibody

Controlled Substance Classification

Not a controlled medication

Generic Status

No lower-cost generic available

Availability

Prescription only

Common questions about Inmazeb

Inmazeb is a combination of three different monoclonal antibodies used to treat infection from Zaire ebolavirus, commonly known as Ebola. Antibodies are proteins your body makes when it sees foreign substances called antigens. They attach to these antigens that are found on viruses, bacteria, and other substances your body doesn't recognize in your blood to help your body get rid of them. Inmazeb targets the Ebola virus in your body and destroys it so it doesn't make you sick. It also prevents the virus from entering into your cells and working normally.

Inmazeb is used to treat Ebola, which can be a deadly infection if not properly cared for. Signs and symptoms include fever, aches and pains, weakness and fatigue, and stomach problems. Ebola is spread through direct contact with an object or bodily fluid contaminated with Ebola virus. If you think you've been exposed to Ebola, seek medical attention right away so you can be tested and treated appropriately.

If you're located in the U.S., Inmazeb might not be readily available. There are selected healthcare facilities in the U.S. that are called designated Ebola treatment centers and might carry this treatment. The manufacturer (Regeneron) is currently supplying the Biomedical Advanced Research and Development Authority (BARDA) with a limited number of Inmazeb until 2026. This is part of the U.S. Department of Health and Human Services' (HHS) goal to be prepared for future public health emergencies. One of Regeneron's other priorities is working to make sure people in low- and middle-income countries where Ebola is more common, like the Democratic Republic of the Congo (DRC), can get this treatment.

Inmazeb is given as an injection through the veins (IV) by a healthcare provider. The IV infusion takes about 2 to 4 hours, depending on your weight.

Common side effects that people experienced during and immediately after the infusion include fever, chills, fast heart rate, fast breathing rate, vomiting, low blood pressure, and diarrhea.

Inmazeb

What is Inmazeb?

Drug facts

Common questions about Inmazeb

Inmazeb dosage

Typical dosage for Inmazeb

Good news for your inbox

Common questions about Inmazeb

What is Inmazeb?

Drug facts

Common questions about Inmazeb

What is Inmazeb and how does it work?

Why is it important to receive Inmazeb if I need it?

Is Inmazeb readily available?

How is Inmazeb given?

What are common side effects with Inmazeb?

Inmazeb dosage

Typical dosage for Inmazeb

Common questions about Inmazeb

What is Inmazeb and how does it work?

Why is it important to receive Inmazeb if I need it?

Is Inmazeb readily available?

How is Inmazeb given?

What are common side effects with Inmazeb?